Distinct clinical and prognostic features of invasive lobular breast cancer

Breast Disease

Volumn 30, Issue , 2008, Pages 39-44

  Petrausch, U ^a   Pestalozzi, Bernhard C ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CARCINOMA; BREAST LOBULAR CARCINOMA; CANCER GRADING; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE FREE SURVIVAL; GYNECOLOGIC CANCER; HUMAN; INVASIVE CARCINOMA; MASTECTOMY; MENINGEAL METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; VISCERAL METASTASIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 70350747603     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-2009-0280     Document Type: Article

References (37)

1. G. Arpino, V.J. Bardou et al., Infiltrating lobular carcinoma of the breast: Tumor characteristics and clinical outcome, Breast Cancer Res 6(3) (2004), R149-156.
2. F. Bertucci, B. Orsetti et al., Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles, Oncogene 27(40) (2008), 5359-5372.
3. M.A. Bollet, A. Savignoni et al., High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies, Br J Cancer 98(4) (2008), 734-741.
4. H.Y. Chang, D.S. Nuyten et al., Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival, Proc Natl Acad Sci USA 102(10) (2005), 3738-3743.
5. A.C. Chiang and J. Massague, Molecular basis of metastasis, N Engl J Med 359(26) (2008), 2814-2823.
6. M. Cristofanilli, A. Gonzalez-Angulo et al., Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes, J Clin Oncol 23(1) (2005), 41-48.
7. D. Dian, H. Herold et al., Survival analysis between patients with invasive ductal and invasive lobular breast cancer, Arch Gynecol Obstet 279(1) (2009), 23-28.
8. C. Fan, D.S. Oh et al., Concordance among gene-expression-based predictors for breast cancer, N Engl J Med 355(6) (2006), 560-569.
9. F.W. Foote, S.F., Lobular carcinoma in situ. A rare form of mammary cancer, American Journal of Pathology 17 (1941), 491-495.
10. U.W. Jayasinghe, A.M. Bilous et al., Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Breast J 13(5) (2007), 479-485.
11. Y. Kang, P.M. Siegel et al., A multigenic program mediating breast cancer metastasis to bone, Cancer Cell 3(6) (2003), 537-549.
12. J.L. Khatcheressian, A.C. Wolff et al., American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting, J Clin Oncol 24(31) (2006), 5091-5097.
13. A. Klein, C. Olendrowitz et al., Identification of brain- and bone-specific breast cancer metastasis genes, Cancer Lett 276 2) (2009), 212-220.
14. T. Korhonen, H. Huhtala et al., A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast, Breast Cancer Res Treat 85(1) (2004), 23-29.
15. J.E. Korkola, S. DeVries et al., Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res 63(21) (2003), 7167-7175.
16. J. Lamovec and M. Bracko, Metastatic pattern of infiltrating lobular carcinoma of the breast: An autopsy study, J Surg Oncol 48 1) (1991), 28-33.
17. X.J. Ma, Z. Wang et al., A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen, Cancer Cell 5(6) (2004), 607-616.
18. M.C. Mathieu, R. Rouzier et al., The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile, Eur J Cancer 40(3) (2004), 342-351.
19. H. Mersin, E. Yildirim et al., Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol 29(4) (2003), 390-395.
20. J.N. Mhuircheartaigh, C. Curran et al., Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma, Br J Surg 95(7) (2008), 827-833.
21. S. Paik, S. Shak et al., A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer, N Engl J Med 351(27) (2004), 2817-2826.
22. G. Peiro, B.A. Bornstein et al., The influence of infiltrating lobular carcinoma on the outcome of patients treated with breastconserving surgery and radiation therapy, Breast Cancer Res Treat 59(1) (2000), 49-54.
23. B.C. Pestalozzi, Brain metastases and subtypes of breast cancer, Ann Oncol 20(5) (2009), 803-805.
24. B.C. Pestalozzi, D. Zahrieh et al., Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: Combined results of 15 International Breast Cancer Study Group clinical trials, J Clin Oncol 26(18) (2008), 3006-3014.
25. E.A. Rakha, M.E. El-Sayed et al., Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes, Eur J Cancer 44(1) (2008), 73-83.
26. R.J. Santiago, E.E. Harris et al., Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience, Cancer 103(12) (2005), 2447-2454.
27. X. Sastre-Garau, M. Jouve et al., Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns, Cancer 77 1) (1996), 113-120.
28. M.J. Silverstein, B.S. Lewinsky et al., Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73 6) (1994), 1673-1677.
29. S.E. Singletary, L. Patel-Parekh et al., Treatment trends in early-stage invasive lobular carcinoma: A report from the National Cancer Data Base, Ann Surg 242(2) (2005), 281-289.
30. P.S. Sinha, S. Bendall et al., Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers? Eur J Surg Oncol 26(8) (2000), 733-737.
31. T. Sorlie, R. Tibshirani et al., Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc Natl Acad Sci USA 100(14) (2003), 8418-8423.
32. C. Sotiriou and L. Pusztai, Gene-expression signatures in breast cancer, N Engl J Med 360(8) (2009), 790-800.
33. M. Tubiana-Hulin, D. Stevens et al., Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: A retrospective study on 860 patients from one institution, Ann Oncol 17(8) (2006), 1228-1233.
34. A.M. Ugnat, L. Xie et al., Survival of women with breast cancer in Ottawa, Canada: Variation with age, stage, histology, grade and treatment, Br J Cancer 90(6) (2004), 1138-1143.
35. M.J. van de Vijver, Y.D. He et al., A gene-expression signature as a predictor of survival in breast cancer, N Engl J Med 347(25) (2002), 1999-2009.
36. T.N. Vo, F. Meric-Bernstam et al., Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma, Am J Surg 192(4) (2006), 552-555.
37. B. Weigelt, H.M. Horlings et al., Refinement of breast cancer classification by molecular characterization of histological special types, J Pathol 216(2) (2008), 141-150.